Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07709195
What this trial is testing

Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant

Who this might be right for
Oral MucositisTotal Body IrradiationHematological Malignancies+1 more
Tata Memorial Centre 17
Testing effectiveness (Phase 2)Ended earlyNCT04762875
What this trial is testing

MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies

Who this might be right for
Related Donors Donating PBSC to a Family MemberHealthy DonorsAcute Myelogenous Leukemia+2 more
Ensoma 7
Early research (Phase 1)Looking for participantsNCT06703892
What this trial is testing

Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Who this might be right for
Diffuse Large B Cell Lymphoma RelapsedDiffuse Large B Cell Lymphoma RefractoryFollicular Lymphoma ( FL)+3 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT01720264
What this trial is testing

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaHematopoetic Myelodysplasia+2 more
Sherif S. Farag 15
Not applicableStudy completedNCT02199548
What this trial is testing

The Good Patient Study

Who this might be right for
Solid TumorHematological MalignanciesBrain Tumor
St. Jude Children's Research Hospital 43
Not applicableStudy completedNCT01069887
What this trial is testing

A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant

Who this might be right for
Hematological MalignanciesStem Cell Transplantation
Catholic University of the Sacred Heart 3,000
Not applicableUnknownNCT06224452
What this trial is testing

Is Ibrutinib-related Atrial Fibrillation Dose Dependent

Who this might be right for
Hematological MalignancyAtrial Fibrillation
University Hospital, Caen 18,000
Early research (Phase 1)Active Not RecruitingNCT03399799
What this trial is testing

Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Hematological Malignancies
Janssen Research & Development, LLC 279
Not applicableStudy completedNCT01404520
What this trial is testing

Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)

Who this might be right for
Acute Leukemia
Universitetshospitalernes Center for Sygepleje 70
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Large-scale testing (Phase 3)Active Not RecruitingNCT06294678
What this trial is testing

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

Who this might be right for
Acute Graft-versus-host Disease
Anhui Provincial Hospital 198
Not applicableStudy completedNCT02824159
What this trial is testing

Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib

Who this might be right for
Hematological Malignancies
University Hospital, Toulouse 121
Early research (Phase 1)Study completedNCT00720785
What this trial is testing

Natural Killer Cells and Bortezomib to Treat Cancer

Who this might be right for
Chronic Myeloid Leukemia (CML)Pancreatic CaColon/Rectal Ca+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Not applicableStudy completedNCT02834156
What this trial is testing

Impact of Child Positioning on Pain During a Lumbar Puncture

Who this might be right for
Hematological Malignancies
Centre Hospitalier Universitaire de Nice 28
Early research (Phase 1)Not Yet RecruitingNCT07532746
What this trial is testing

A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies

Who this might be right for
Relapsed or Refractory EBV-associated Hematological Malignancies
Kousai Bio Co., Ltd. 55
Not applicableStudy completedNCT01669005
What this trial is testing

The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies

Who this might be right for
Neutropenia
Centre Hospitalier Universitaire Vaudois 84
Early research (Phase 1)Study completedNCT02576496
What this trial is testing

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Hematological MalignanciesMultiple MyelomaHodgkin's Lymphoma+1 more
Mundipharma Research Limited 106
Large-scale testing (Phase 3)Study completedNCT00275678
What this trial is testing

Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies

Who this might be right for
Blood Stem Cell Transplant
Mayo Clinic 15
Not applicableStudy completedNCT00547196
What this trial is testing

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
City of Hope Medical Center 10
Not applicableUnknownNCT06041815
What this trial is testing

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Who this might be right for
Hematological MalignanciesChimeric Antigen Receptor T-cell Therapy
The First Affiliated Hospital of Soochow University 100
Next Page